| Cutaneous Lymphoma studied in …STUDIED_INderived200 of 360show all (up to 200) |
|---|
| → studied in | NCT01087333recruiting Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05627245Phase 1 · active not recruiting Testing the Safety of the Anti-cancer Drugs Tazemetostat and Belinostat in Patients With Lymphomas That Have Resisted Treatment · condition mapped CURATED_BROADER · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05944562Phase 1 · active not recruiting Tulmimetostat (DZR123) in Patients With Mycosis Fungoides and Sézary Syndrome · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07003100recruiting A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab · condition mapped CURATED_BROADER · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05589896Phase 1/Phase 2 · active not recruiting A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07710781NA · not yet recruiting Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06285370Phase 4 · completed A Study to Evaluate the Efficacy and Safety of KW-0761 in Chinese Subjects With Mycosis Fungoides or Sézary Syndrome Previously Treated With Systemic Therapy · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06854653Phase 2 · recruiting A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03380026Phase 2 · completed Mechlorethamine Induced Contact Dermatitis Avoidance Study · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04930653Phase 2 · recruiting Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Folliculotropic Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07758491Phase 1/Phase 2 · not yet recruiting A Phase I/II Study of FG-M131 in TRBC1+ Relapsed/Refractory Peripheral T-Cell Lymphoma · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04904146recruiting Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome. · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07781449Phase 2 · not yet recruiting Topical JAK-Inhibition of Early-Stage CTCL · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07055477Phase 1 · recruiting A Phase I Trial Anti-CC Chemokine Receptor 4 Chimeric Antigen Receptor T Cells (CCR4 CAR T Cells) for CCR4 Expressing T-cell Malignancies Including Peripheral T-cell Non-Hodgkin Lymphoma (PTCL) and Cutaneous T-cell Non-Hodgkin Lymphoma (CTCL) · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02702310suspended Low-Dose Total Skin Electron Therapy in Treating Patients With Refractory or Relapsed Stage IB-IIIA Mycosis Fungoides · condition mapped CURATED_BROADER · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02978625Phase 2 · active not recruiting Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers · condition mapped CURATED_BROADER · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03409432Phase 2 · completed Brentuximab Vedotin and Lenalidomide in Treating Patients With Stage IB-IVB Relapsed or Refractory T-Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Primary Cutaneous Anaplastic Large Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04447027Phase 1 · completed Romidepsin, CC-486 (5-azacitidine), Dexamethasone, and Lenalidomide (RAdR) for Relapsed/Refractory T-cell Malignancies · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07754890Phase 1/Phase 2 · recruiting Golidocitinib and Chidamide for Cutaneous T-Cell Lymphoma · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03011814Phase 1/Phase 2 · recruiting Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Folliculotropic Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05357794Phase 2 · recruiting Effectiveness of Concurrent Ultra-Low-Dose Total-Skin Electron Beam Therapy and Brentuximab Vedotin Given Quarterly Over 12 Months for Patients With Mycosis Fungoides · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04045470NA · recruiting A Pilot of a Microdevice For In Situ Candidate Drug Screening in Cutaneous Lesions of T-Cell Lymphoma · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07717580Phase 2 · not yet recruiting Efficacy and Safety of Brentuximab Vedotin Combined With Lisaftoclax in CD30+ Cutaneous T-cell Lymphoma (CTCL) · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05377827Phase 1 · suspended Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Transformed Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05821088Phase 2 · active not recruiting Tafasitamab and Lenalidomide Followed by Tafasitamab and ICE as Salvage Therapy for Transplant Eligible Patients With Relapsed/ Refractory Large B-Cell Lymphoma · condition mapped CURATED_BROADER · 360 trials mapped (91 active) | — | — | Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07714187Phase 1 · not yet recruiting A Study of Topical Duvelisib in Participants With Early-stage Mycosis Fungoides · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01352520Phase 2 · active not recruiting SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP) · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Cutaneous Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06207812recruiting Long-term Outcomes Associated With Juvenile-onset Mycosis Fungoides and Lymphomatoid Papulosis · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07705386active not recruiting Development of an AI-Assisted Diagnostic Tool for Mycosis Fungoides and Other Cutaneous Lymphoproliferative Diseases Using Microscopic Image Analysis: A Training and Validation Study · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06580002Phase 2 · recruiting Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06470451Phase 3 · terminated Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06698822Phase 2 · recruiting A Phase 2 Trial to Assess Safety and Efficacy of Tofacitinib 2% Cream in the Treatment of Cutaneous T-cell Lymphoma (CTCL), Stages IA, IB, and IIA · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07691450Phase 1 · not yet recruiting Belinostat in Combination With Azacitidine or Pralatrexate for the Treatment of Relapse or Refractory T-cell Lymphoma · condition mapped CURATED_BROADER · 360 trials mapped (91 active) | — | — | Primary Cutaneous CD8-Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04799275Phase 2/Phase 3 · active not recruiting Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04256018Phase 2 · recruiting Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06508463Phase 1 · recruiting Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06860880NA · recruiting Combating Cancer-Related Fatigue: A Personalized Supportive Care Program · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02520791Phase 1 · active not recruiting Anti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Follicular Variant or Angioimmunoblastic T-cell Lymphoma · condition mapped CURATED_BROADER · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01815749Phase 1 · active not recruiting Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07658924Phase 2 · not yet recruiting Efficacy and Safety of Benvitimod Cream in Cutaneous T-Cell Lymphoma · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05475925Phase 1/Phase 2 · recruiting A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Primary Cutaneous Gamma-Delta T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01787409NA · active not recruiting Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Primary Cutaneous Anaplastic Large Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05414500Phase 1 · suspended Mogamulizumab and Brentuximab Vedotin in CTCL and Mycosis Fungoides · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02232516Phase 2 · completed Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma · condition mapped CURATED_BROADER · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03602157Phase 1 · active not recruiting Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Cutaneous Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04960618Phase 2 · active not recruiting Pembrolizumab in Combination With Gemcitabine in People With Advanced Mycosis Fungoides or Sézary Syndrome · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03017820Phase 1 · recruiting A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma · condition mapped CURATED_BROADER · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06113081completed Real World Experience With Mogamulizumab in the Treatment of Cutaneous T-cell Lymphoma · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07608549NA · not yet recruiting FLASH Pilot Phase 1 Safety Study · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Cutaneous Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03598998Phase 1/Phase 2 · active not recruiting Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas · condition mapped CURATED_BROADER · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05978141recruiting A Registry for People With T-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Subcutaneous Panniculitis-Like T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02943642Phase 2 · withdrawn Safety and Effectiveness of A-dmDT390-bisFv(UCHT1) Fusion Protein in Subjects With Mycosis Fungoides · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03038672Phase 2 · active not recruiting Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas · condition mapped CURATED_BROADER · 360 trials mapped (91 active) | — | — | Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05956041Phase 2 · recruiting Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03932279recruiting Characterization of the Microbiome in Cutaneous T Cell Lymphoma · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05728879early Phase 1 · not yet recruiting Characterization of the Microbiome in Cutaneous T Cell Lymphoma Skin Lesions Before and After Use of APR-TD011® (RLF-TD011®) Spray Solution · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05838599early Phase 1 · recruiting Combining Topical Imiquimod With Local Radiotherapy for Treatment of Mycosis Fungoides · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06665490enrolling by invitation Pilot Study to Characterize the Microbiome in Cutaneous T Cell Lymphoma Skin Lesions Before and After Use of CLn® Skin Care Body Wash · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05680558Phase 2 · recruiting Photopheresis in Early-stage Mycosis Fungoides · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05507541Phase 2 · active not recruiting TTI-622 in Combination With Pembrolizumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma · condition mapped CURATED_BROADER · 360 trials mapped (91 active) | — | — | Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07535710Phase 1/Phase 2 · not yet recruiting Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Treated Cutaneous T-cell Lymphoma · condition mapped CURATED_BROADER · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01384513Phase 2 · completed A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies · condition mapped CURATED_BROADER · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03398161Phase 2 · recruiting Ultra Low Dose Radiation Therapy in Treating Patients With Mycosis Fungoides · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07356245Phase 2 · recruiting Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07529405Phase 2 · not yet recruiting A Study of VG712 in Patients With Mycosis Fungoides · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03240211Phase 1 · active not recruiting Study of Pembrolizumab Combined With Decitabine and Pralatrexate in PTCL and CTCL · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03587844Phase 2 · recruiting Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07047885Phase 1 · recruiting Ropeginterferon in Patients w/Cutaneous T-Cell Lymphoma (CTCL) · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02213913Phase 1/Phase 2 · completed Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06235281early Phase 1 · suspended Phototherapy and Mogamulizumab in Early Stage MF (PLIGHT) · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05544019Phase 1 · recruiting Study of SGR-1505 in Mature B-Cell Neoplasms · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Primary Cutaneous Follicle Center Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04848064Phase 1 · recruiting Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma · condition mapped CURATED_BROADER · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05872854Phase 2 · completed Treatment of Mycosis Fungoides With Hypericin Ointment and Visible Light · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06485219Phase 2 · active not recruiting A Phase IIa Clinical Study of Purinostat Mesylate for Injection in Patients With Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05296304Phase 1 · recruiting A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01199562active not recruiting Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04670874recruiting Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29 · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Cutaneous Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06834373Phase 2 · recruiting Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy · condition mapped CURATED_BROADER · 360 trials mapped (91 active) | — | — | Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07362225recruiting MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs) · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03278782Phase 1/Phase 2 · active not recruiting Study of Pembrolizumab (MK-3475) in Combination With Romidepsin · condition mapped CURATED_BROADER · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04686682Phase 1/Phase 2 · recruiting A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00177268recruiting Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07283822Phase 2 · recruiting Amping up With PemJAK · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06588868recruiting Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07235813NA · completed IL-35: A Key Immunosuppressive Driver in Mycosis Fungoides Modulated by Phototherapy · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06716658Phase 2 · recruiting JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02848274recruiting ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04541017Phase 1/Phase 2 · terminated Testing the Addition of an Anti-cancer Drug, Hu5F9-G4 (Magrolimab), to the Usual Chemotherapy Treatment (Mogamulizumab) in T-Cell (a Type of Immune Cell) Lymphoma That Has Returned After Treatment or Does Not Respond to Treatment · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06712810Phase 1 · recruiting Q702 for the Treatment of Patients With Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07213882early Phase 1 · not yet recruiting A Phase 1, Multicenter, Open-label, Prospective, First-in-human Dose-escalation Clinical Trial of Domain Therapeutics' Anti-CCR8 Monoclonal Antibody (DT-7012) in Patients With Relapsed or Refractory Cutaneous T-cell Lymphomas (CTCL) · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04074746Phase 1/Phase 2 · completed Modified Immune Cells (AFM13-NK) and A Monoclonal Antibody (AFM13) in Treating Patients With Recurrent or Refractory CD30 Positive Hodgkin or Non-Hodgkin Lymphomas · condition mapped CURATED_BROADER · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04234048Phase 1 · recruiting Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07132567recruiting Assessment of Safety and Efficacy of Poteligeo Inj. 20 mg (Mogamulizumab) Through Use-result Surveillance · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02512497Phase 1 · completed Romidepsin Maintenance After Allogeneic Stem Cell Transplantation · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07178457Phase 3 · not yet recruiting Brentuximab Vedotin in CutAneous T-cell Lymphomas (CTCL): Post-allogeneic Hematopoietic Stem Cell Transplant Maintenance · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03695471Phase 2 · completed Pembrolizumab in Treating Patients With Stage IB-IV Mycosis Fungoides · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06149247Phase 2 · completed HyBryte (Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCL · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07021495recruiting SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY) · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05879458Phase 2 · terminated Ritlecitinib in CTCL · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06385522Phase 1 · not yet recruiting A Clinical Trial in Adults With Non-Hodgkin Lymphoma (NHL), With a Particular Emphasis on Cutaneous T Cell Lymphoma (CTCL), Testing the Safety and Activity of a Novel Drug to Inhibit a Protein Called Tumor Necrosis Factor Receptor 2 That Drives Both Lymphoma Growth and Escape of the Immune System · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07046663not yet recruiting Long-term Assessment of Chlormethine Gel in Mycosis Fungoides · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05538988Phase 1/Phase 2 · withdrawn BIOmarker-guided Study to Evaluate the Efficacy and Safety of cemipLimab for advancEd Cutaneous T-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05106192NA · withdrawn Triamcinolone Acetonide Injections in Primary Cutaneous Lymphoma Plaques With a Novel Needle-free Drug-delivery System. · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03432741Phase 1 · terminated Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast Cancer · condition mapped CURATED_BROADER · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00368784completed T Cell Repertoire Analysis of Immune Mediated Skin Diseases · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02548468Phase 1 · withdrawn Reduced Intensity Conditioning Before Partially Matched Donor Stem Cell Transplant in Treating Patients With Advanced Cutaneous T Cell Lymphoma · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06382844recruiting Novel Flow-cytometry Approaches to Improve the Detection of Tumor Cells in CTCL · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03288818Phase 2 · withdrawn Low Dose Total Skin Electron Beam Radiation Therapy and Mechlorethamine Hydrochloride Gel in Treating Patients With Mycosis Fungoides · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06914037Phase 1 · recruiting A Clinical Study of CHT101 in CD70-Positive Relapsed or Refractory Hematological Malignancies · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02616965Phase 1 · completed A Study to Assess the Feasibility of Romidepsin Combined With Brentuximab Vedotin in Cutaneous T-cell Lymphoma · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02342782Phase 1 · completed Yttrium Y 90 Basiliximab and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Mature T-cell Non-Hodgkin Lymphoma · condition mapped CURATED_BROADER · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05225584Phase 1 · completed Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04312841Phase 2 · completed Letermovir for the Prevention of Cytomegalovirus Reactivation in Patients With Hematological Malignancies Treated With Alemtuzumab · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04072458Phase 1 · active not recruiting A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignancies · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01638533Phase 1 · completed Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction · condition mapped CURATED_BROADER · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06782854completed Understanding the Role of Large Extracellular Vesicles in Lymphomas and Lymphoproliferative Disorders: the "Off the Beaten Track" Liquid Biopsy · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04774068Phase 1 · completed Romidepsin and Parsaclisib for the Treatment of Relapsed or Refractory T-Cell Lymphomas · condition mapped CURATED_BROADER · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03385226Phase 2 · active not recruiting A Trial Assessing the Effect of Pembrolizumab Combined with Radiotherapy in Patients with Relapsed, Refractory, Specified Stages of Cutaneous T-cell Lymphoma (CTCL) Mycosis Fungoides (MF)/Sezary Syndrome (SS) · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05333367NA · recruiting MORPHEE : Mechanisms of Cell Death Induced by Extracorporeal Photochemotherapy · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04101331Phase 2 · completed Phase II Study to Assess AFM13 in Patients With R/R CD30-positive T-cell Lymphoma or Transformed Mycosis Fungoides · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Transformed Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03493451Phase 2 · completed Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06651203not yet recruiting Evaluation of the KIR3DL2 Marker in Flow Cytometry for Sézary Syndrome Diagnosis, Therapeutic Response and Residual Disease: a Prospective and Multicenter Study · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05202782Phase 2 · active not recruiting Zanubrutinib and CAR T-cell Therapy for the Treatment of Recurrent or Refractory Aggressive B-cell Non-Hodgkin's Lymphoma or Transformed Indolent B-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01460914completed Outcomes of Cutaneous T-Cell Lymphoma and Graft-Versus-Host Disease With Extracorporeal Photopheresis Treatment · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02953301Phase 2 · completed Resminostat for Maintenance Treatment of Patients With Advanced Stage Mycosis Fungoides (MF) or Sézary Syndrome (SS) · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04676087Phase 1/Phase 2 · terminated Mogamulizumab and Extracorporeal Photopheresis for the Treatment of Sezary Syndrome or Mycosis Fungoides · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02192021Phase 1 · completed Micro Needle Array-Doxorubicin (MNA-D) in Patients With Cutaneous T-cell Lymphoma (CTCL) · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02576496Phase 1 · completed Study of Tinostamustine, First-in-Class Alkylating HDACi Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04014374recruiting Post-authorization Safety Study of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Treated With Mogamulizumab · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00341939completed Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06436677recruiting A Study of Molecular Subtyping-based Therapeutic Strategies for Cutaneous T-cell Lymphoma · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03789864NA · terminated Biodynamic Imaging Utility in Predicting Response to Gemcitabine Chemotherapy in Mycosis Fungoides · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06421571unknown The Mechanism of Action of Chlormethine (CL) Gel in the Treatment of MF-CTCL Adult Patients · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01226472Phase 2 · completed Extension Study in Subjects Who Relapsed After Complete Response on Study KW-0761-001 · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01728805Phase 3 · completed Study of KW-0761 Versus Vorinostat in Relapsed/Refractory CTCL · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04745234Phase 2 · unknown Mogamulizumab Q4week Dosing in Participants With R/R CTCL · condition mapped CURATED_BROADER · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01588015Phase 1 · completed Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant · condition mapped CURATED_BROADER · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02168140Phase 1 · completed CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma · condition mapped CURATED_BROADER · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05904522NA · unknown Histopathological Changes in Mycosis Fungoides · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01769222Phase 1 · terminated Ipilimumab and Local Radiation for Selected Solid Tumors · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01523223Phase 1 · completed Donor Peripheral Stem Cell Transplant in Treating Patients With Hematolymphoid Malignancies · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05518851recruiting TreAtments and outComes in paTients With prImary CutAneous Lymphoma · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Primary Cutaneous Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00047060Phase 1/Phase 2 · completed Stem Cell Transplant Therapy With Campath-1H for Treating Advanced Mycosis Fungoides and Sezary Syndrome · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05138458Phase 1/Phase 2 · suspended A Study of MT-101 in Subjects With CD5+ Relapsed/Refractory TCL · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04795869Phase 2 · withdrawn Brentuximab Vedotin and Pembrolizumab in Treating Patients With Recurrent Peripheral T-Cell Lymphoma · condition mapped CURATED_BROADER · 360 trials mapped (91 active) | — | — | Subcutaneous Panniculitis-Like T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05329792Phase 2 · unknown L19IL2/L19TNF in Skin Cancer Patients · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01000753completed Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Primary Cutaneous B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05781386Phase 1 · unknown A Phase I Trial of SIM1811-03 in Subjects With Advanced Tumors · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06037239Phase 1/Phase 2 · unknown Phase I/II Study of Linperlisib Plus Chidamide for R/R Cutaneous T-cell Lymphoma: a Prospective, Single-center Study · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01044745Phase 2 · terminated Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic Cancer · condition mapped CURATED_BROADER · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05380635Phase 2 · completed PK and ECG Determinations Following 8 Weeks of HyBryte Treatment for Cutaneous T-Cell Lymphoma · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00071071Phase 2 · completed Clinical Trial of HuMax-CD4, a New Drug to Treat Early Stage T-Cell Lymphoma in the Skin. · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01579318Phase 2 · terminated Phase II Intratumoral IL12 Plasmid Electroporation in Cutaneous Lymphoma · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00896493Phase 2 · completed Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05855460unknown Estimation of the Tissue and Serum Levels of Interleukin (IL) -35 in Mycosis Fungoides: a Case Control Study · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00071084Phase 2 · completed Clinical Trial of HuMax-CD4, a New Drug to Treat Advanced Stage T-Cell Lymphoma in the Skin. · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02890368Phase 1 · terminated Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02546440Phase 2 · completed Study on Therapy With Dimethylfumarate (DMF) in Patients With Cutaneous T Cell Lymphoma (CTCL) · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05526638NA · unknown Serum and Tissue Level of Interleukin-15 (IL-15) and IL-15 Receptor Alpha (IL-15Rα) in Mycosis Fungoides · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02314247Phase 2 · terminated Efficacy and Safety Study of Selinexor in Relapsed or Refractory Peripheral T-cell Lymphoma or Cutaneous T-cell Lymphoma · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05303480NA · completed Deep Phenotyping of Cutaneous T Cell Lymphoma, Type Mycosis Fungoides · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03109353Phase 1/Phase 2 · completed Modification of Extracorporeal Photopheresis in Cutaneous T-cell Lymphoma or Chronic Graft-versus-host Disease · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03281811early Phase 1 · completed Photodynamic Therapy in Treating Patients With Refractory Mycosis Fungoides · condition mapped CURATED_BROADER · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04185220Phase 1 · completed Phase I Study of Recombinant Human IL-15 (rhIL-15) and Mogamulizumab for People With Refractory or Relapsed Adult T-Cell Leukemia and Mycosis Fungoides/Sezary Syndrome · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03775525Phase 1 · unknown Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02643303Phase 1/Phase 2 · completed A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02811783Phase 3 · terminated Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04118868Phase 1 · unknown Pembrolizumab Administered Via the Sofusa® DoseConnect™ in Patients With Relapsed/Refractory Cutaneous T-cell Lymphoma. · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05569057Phase 1 · unknown A Phase I Trial of SIM1811-03 in Subjects With Advanced Solid Tumors and Cutaneous T-cell Lymphoma · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03905135Phase 1 · completed Interleukin-15 (IL-5) in Combination With Avelumab (Bavencio) in Relapsed/Refractory Mature T-cell Malignancies · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05156229Phase 1 · terminated A Phase 1/2a Study of CDK-003 in Patients With Cutaneous T-Cell Lymphoma (CTCL). · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05414162unknown Multiparametric Cardiac MRI in Patients Under CAR T-cell Therapy · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02883517completed Cell-free Circulating DNA in Primary Cutaneous Lymphomas · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02689453Phase 1 · completed Subcutaneous Recombinant Human IL-15 (s.c. rhIL-15) and Alemtuzumab for People With Refractory or Relapsed Chronic and Acute Adult T-cell Leukemia (ATL) · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02448381Phase 3 · completed FLASH [Fluorescent Light Activated Synthetic Hypericin] Clinical Study: Topical SGX301 (Synthetic Hypericin) for the Treatment of Cutaneous T-Cell Lymphoma (Mycosis Fungoides) · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03713320Phase 2 · terminated SOLAR: Efficacy and Safety of Cobomarsen (MRG-106) vs. Active Comparator in Subjects With Mycosis Fungoides · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04491825unknown Diagnostic Classifier for Cutaneous T-cell Lymphomas · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03458117Phase 1 · completed T-VEC in Non-melanoma Skin Cancer · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Cutaneous Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04955340Phase 1 · completed A Phase 1, Open-label Study of the Absorption, Metabolism, Excretion of [14C]-Resminostat · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05205902Phase 3 · not yet recruiting TOtal Skin Electron Beam Therapy (Low-dose) for Tumor Clone Eradication in Early-stage Mycosis Fungoides · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02323659Phase 4 · terminated Comparison of Methotrexate Versus Interferon-alfa 2b in Patients With Primary Cutaneous T-cell Lymphomas · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00476554Phase 2 · terminated A Randomized Phase II Study of Oral Sapacitabine in Patients With Advanced Cutaneous T-cell Lymphoma · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01445535Phase 1 · completed Phase 1 Trial of Siplizumab and Dose-Adjusted EPOCH-Rituximab in T- and NK-Cell Lymphomas · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Subcutaneous Panniculitis-Like T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01805037Phase 1/Phase 2 · terminated Brentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ Lymphomas · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00425555Phase 2 · completed Study of Oral LBH589 in Adult Patients With Refractory Cutaneous T-Cell Lymphoma · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00490776Phase 2 · terminated Study of Oral LBH589 in Adult Participants With Refractory/Resistant Cutaneous T-Cell Lymphoma (CTCL) · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02676778Phase 2 · completed Study of E7777 in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma and Cutaneous T-cell Lymphoma · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04171791Phase 1 · completed A Study of ABT-199 (Venetoclax) for Cutaneous T Cell Lymphoma (CTCL) · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03239392Phase 1/Phase 2 · completed A Dose-Ranging Study of IV BNZ-1 in LGL Leukemia or Refractory CTCL · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02037256NA · completed Bortezomib and Filgrastim to Promote Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02301494NA · withdrawn Effectiveness of Imiquimod Topical Cream in Early Stage Cutaneous T-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02341209Phase 2 · terminated Doxycycline for the Treatment of Cutaneous T-Cell Lymphoma · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00536601NA · completed High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors · condition mapped CURATED_BROADER · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03292406Phase 2 · completed A Safety, Efficacy and Pharmacokinetics Study of CD11301 for the Treatment of Cutaneous T-Cell Lymphoma (CTCL) · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01678443Phase 1 · terminated Monoclonal Antibody Therapy Before Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoid Malignancies · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00489203Phase 2 · completed Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer · condition mapped CURATED_BROADER · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02593045Phase 1 · completed Study of IPH4102 in Patients With Relapsed/Refractory Cutaneous T-cell Lymphomas (CTCL) · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04702503Phase 1 · completed Study of WP1220 for the Treatment of Adult Subjects With Cutaneous T-Cell Lymphoma (CTCL) · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Mycosis Fungoides | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01578499Phase 3 · completed A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Participants With CD30-Positive Cutaneous T-Cell Lymphoma (ALCANZA Study) · condition mapped ONTOLOGY_EXACT · 360 trials mapped (91 active) | — | — | Primary Cutaneous Anaplastic Large Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02580552Phase 1 · completed Safety, Tolerability and Pharmacokinetics of MRG-106 in Patients With Mycosis Fungoides (MF), CLL, DLBCL or ATLL · condition mapped ALIAS · 360 trials mapped (91 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |